Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO is Breaking Out -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (899)	3/28/2000 4:26:00 PM
From: James Strauss	Read Replies (1) \| Respond to of 1018

Sergio: If the $35.00 net average profit for Painbuster and On-Q is correct, it would be hard for IFLO not to have an eps north of $9.00... We'll have to see what market share they currently have, and project forward... A 10% market share is reasonable to expect from a company that's setting a new standard for narcotic free pain medication delivery... I'd prefer that IFLO not be bought out at $15.00 or $20.00 for the quick buck... I think the stock would be worth much more if IFLO remains independent... What's your sense about this... Jim